LT3965752T - Farmacinis derinys, apimantis trazodoną, skirtas neuropatinio skausmo gydymui - Google Patents

Farmacinis derinys, apimantis trazodoną, skirtas neuropatinio skausmo gydymui

Info

Publication number
LT3965752T
LT3965752T LTEPPCT/IB2020/054275T LTIB2020054275T LT3965752T LT 3965752 T LT3965752 T LT 3965752T LT IB2020054275 T LTIB2020054275 T LT IB2020054275T LT 3965752 T LT3965752 T LT 3965752T
Authority
LT
Lithuania
Prior art keywords
treatment
neuropathic pain
pharmaceutical combination
combination containing
trazodone
Prior art date
Application number
LTEPPCT/IB2020/054275T
Other languages
English (en)
Inventor
Lorenzo Polenzani
Fabrizio CALISTI
Paola LIPONE
Serena Tongiani
Original Assignee
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=67875917&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3965752(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. filed Critical Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Publication of LT3965752T publication Critical patent/LT3965752T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTEPPCT/IB2020/054275T 2019-05-07 2020-05-06 Farmacinis derinys, apimantis trazodoną, skirtas neuropatinio skausmo gydymui LT3965752T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102019000006602A IT201900006602A1 (it) 2019-05-07 2019-05-07 Composizione farmaceutica per il trattamento del dolore neuropatico
PCT/IB2020/054275 WO2020225740A1 (en) 2019-05-07 2020-05-06 Pharmaceutical combination comprising trazodone for the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
LT3965752T true LT3965752T (lt) 2023-11-10

Family

ID=67875917

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/IB2020/054275T LT3965752T (lt) 2019-05-07 2020-05-06 Farmacinis derinys, apimantis trazodoną, skirtas neuropatinio skausmo gydymui

Country Status (27)

Country Link
US (1) US20220211699A1 (lt)
EP (1) EP3965752B1 (lt)
JP (2) JP7695204B2 (lt)
KR (1) KR102916437B1 (lt)
CN (1) CN113825505B (lt)
AU (1) AU2020267954B2 (lt)
BR (1) BR112021021410A2 (lt)
CA (1) CA3135097A1 (lt)
DK (1) DK3965752T3 (lt)
EA (1) EA202193050A1 (lt)
ES (1) ES2962966T3 (lt)
FI (1) FI3965752T3 (lt)
GE (2) GEP20237524B (lt)
HR (1) HRP20231252T1 (lt)
HU (1) HUE063756T2 (lt)
IL (1) IL287529B2 (lt)
IT (1) IT201900006602A1 (lt)
LT (1) LT3965752T (lt)
MX (1) MX2021013489A (lt)
PL (1) PL3965752T3 (lt)
PT (1) PT3965752T (lt)
RS (1) RS64783B1 (lt)
SG (1) SG11202110709QA (lt)
SI (1) SI3965752T1 (lt)
SM (1) SMT202300316T1 (lt)
UA (1) UA128174C2 (lt)
WO (1) WO2020225740A1 (lt)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1274306C (zh) * 2001-09-03 2006-09-13 纽朗制药有限公司 包含加巴喷丁或其类似物和α－氨基酰胺的药物组合物及其止痛应用
ATE449633T1 (de) 2003-09-12 2009-12-15 Pfizer Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
US20080096872A1 (en) * 2004-12-22 2008-04-24 Friedman Robert S Composition for Treatment of Pain Specification
US20120083508A1 (en) * 2006-12-22 2012-04-05 Allergan, Inc. Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain
EP2184986A4 (en) * 2007-08-06 2010-12-15 Trinity Lab Inc PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC PAIN AND PAIN RELATING TO NEUROPATHY
WO2013002584A2 (ko) 2011-06-28 2013-01-03 주식회사 비보존 다중 타겟팅의 상승 효과를 유발하는 유효물질의 조합 및 그 용도
WO2017067870A1 (en) * 2015-10-22 2017-04-27 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Combination of trazodone and gabapentin for the treatment of pain

Also Published As

Publication number Publication date
AU2020267954A1 (en) 2021-10-28
JP2025076496A (ja) 2025-05-15
UA128174C2 (uk) 2024-04-24
DK3965752T3 (da) 2023-10-09
KR102916437B1 (ko) 2026-01-23
MX2021013489A (es) 2021-12-10
SMT202300316T1 (it) 2024-01-10
PT3965752T (pt) 2023-10-02
BR112021021410A2 (pt) 2021-12-21
RS64783B1 (sr) 2023-11-30
FI3965752T3 (fi) 2023-10-04
JP7695204B2 (ja) 2025-06-18
IT201900006602A1 (it) 2020-11-07
CN113825505A (zh) 2021-12-21
CN113825505B (zh) 2025-12-16
HUE063756T2 (hu) 2024-01-28
WO2020225740A1 (en) 2020-11-12
CA3135097A1 (en) 2020-11-12
EP3965752A1 (en) 2022-03-16
GEAP202315820A (en) 2023-03-10
HRP20231252T1 (hr) 2024-02-02
US20220211699A1 (en) 2022-07-07
JP2022532518A (ja) 2022-07-15
PL3965752T3 (pl) 2024-01-29
AU2020267954B2 (en) 2025-07-03
SG11202110709QA (en) 2021-11-29
IL287529A (en) 2021-12-01
GEP20237524B (en) 2023-08-10
EA202193050A1 (ru) 2022-02-10
SI3965752T1 (sl) 2023-12-29
ES2962966T3 (es) 2024-03-22
EP3965752B1 (en) 2023-08-30
KR20220006049A (ko) 2022-01-14
IL287529B (en) 2022-05-01
IL287529B2 (en) 2025-09-01

Similar Documents

Publication Publication Date Title
EP3601291B1 (en) 11,13-Modified Saxitoxins for the Treatment of Pain
EP3935050C0 (en) HETEROCYCLIC COMPOUNDS FOR MEDICAL TREATMENT
HUE060711T2 (hu) Makrociklusos vegyületek betegségek kezelésére
EP3684418C0 (en) COMPOUNDS FOR THE TREATMENT OF CYSTEAMINE-RESPONSIVE DISORDERS
MX2019014041A (es) Inhibidores pirazolicos de magl.
BR112017003054A2 (pt) compostos de aminopirimidinila como inibidores de jak
IL279260A (en) KDM1A inhibitors for the treatment of diseases
EA201692436A1 (ru) Медицинское применение
EP3256218A4 (en) Kdm1a inhibitors for the treatment of disease
IL272601A (en) Pharmaceutical compositions for the treatment of ophthalmic conditions
CR20190536A (es) Inhibidores pirazólicos de magl
PL3424499T3 (pl) Kompozycja farmaceutyczna do leczenia bólu neuropatycznego
HUE059584T2 (hu) Gyógyszerészeti készítmény vérszegénység kezelésére
EA201991898A1 (ru) Двойные ингибиторы magl и faah
HUE057063T2 (hu) Topikális gyógyászati készítmény, amely legalább amitriptilint tartalmaz, perifériás neuropátiás fájdalom kezelésére
LT3377094T (lt) Susilpninto virulentiškumo bakterijos, skirtos piktybinių solidinių navikų gydymui
IL276482A (en) Compounds for pain management
IL282700A (en) Heterocyclic compounds for the treatment of epilepsy
DK3403674T3 (da) Farmaceutiske sammensætninger til behandling af smerte
LT3124048T (lt) Kompozicija skirta vartoti per burną gastroezofaginio refliukso ligos ar skausmo gydymui
LT3743043T (lt) Farmacinės kompozicijos, skirtos pooperacinio skausmo gydymui
EP3890731A4 (en) COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION
HUE053924T2 (hu) Kompozíció cukorbetegség kezelésére
LT3519050T (lt) Kompozicijos, skirtos oftalmologinių būklių gydymui
PL4009942T3 (pl) Związek służący do leczenia skojarzonego